Cyclothymic disorder in youth: why is it overlooked, what do we know and where is the field headed? by Van Meter, Anna R. & Youngstrom, Eric A.
Cyclothymic disorder in youth: why is it overlooked, what do we
know and where is the field headed?
Anna R Van Meter*,1 and Eric A Youngstrom1
1University of North Carolina at Chapel Hill, NC 27514, USA
SUMMARY
Cyclothymic disorder is a chronic and impairing subtype of bipolar disorder, largely neglected in
pediatric research. Consequently, it is rarely diagnosed clinically despite potentially being the
most prevalent form of bipolar disorder. Lack of attention has added to confusion about the
diagnosis and clinical presentation of cyclothymic disorder. In pediatric studies, cyclothymic
disorder is commonly grouped with ‘subthreshold’ presentations of bipolar disorder under the
undifferentiated label ‘bipolar disorder not otherwise specified’. However, research indicates that
cyclothymic disorder can be reliably distinguished from the other forms of bipolar disorder and
from other childhood disorders. Importantly, cyclothymic disorder may be a diathesis for more
acute presentations of bipolar disorder, warranting a prominent role in dimensional models of
mood and psychopathology. Current evidence suggests that cyclothymic disorder has the potential
to make unique contributions to our understanding of the risk factors and outcomes associated
with bipolar disorder. This potential has yet to be fully realized, limiting our knowledge and
ability to intervene in a meaningful way with youth who are exhibiting symptoms of a major mood
disorder. Including cyclothymic disorder in future research studies of children – particularly
longitudinal outcome studies – is essential for understanding the developmental trajectory of
bipolar spectrum disorders and learning how to accurately diagnosis and treat the full spectrum of
bipolar disorders.
Cyclothymia has been part of the nomenclature in psychiatry since the 1880s, and during the
time since then, has been conceptualized in a number of different ways across several
theoretical models. Currently, some think of cyclothymic disorder as a subtype of bipolar
disorder [1], characterized by a chronic presentation of low-grade depressive and hypomanic
symptoms. Cyclothymia is also described as a temperament style [2], associated with
moodiness and irritability. Cyclothymic temperament is thought to be a risk factor for
psychopathology, particularly in the bipolar spectrum disorders [3]. The concept of
‘temperament as diathesis’ aligns well with the conceptualization of cyclothymic disorder as
a prodrome or intermediate stage in the development of bipolar I or II [4]. Cyclothymia has
also been considered a character trait that might not have any direct relation to
psychopathology [5]. This range of definitions, applied to a single term, has led to
confusion, misinterpretation and, ultimately, limited attention. As a dimensional model of
diagnosis gains favor, cyclothymic disorder may become an increasingly important
developmental construct between nonclinical levels of mood fluctuation and acute bipolar
disorder. Pediatric bipolar disorder continues to be controversial, with questions regarding
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its phenomenology and course remaining unresolved. Cyclothymic disorder may be an
important key to understanding the progression from ‘childhood moodiness’ into a mood
disorder. The anticipated publication of new versions of both the DSM and International
Classification of Diseases provides an opportunity to examine the data on cyclothymic
disorder in youth and to decide how it best fits in with contemporary psychiatry and
psychology.
Available data on cyclothymic disorder in youth are limited. To date there are fewer than
five clinical studies published that have included it as a diagnostic category and it is not
specifically included in epidemiological studies. The lack of published information about
cyclothymic disorder is not related to its prevalence or degree of associated impairment. The
goal of this review is to bring attention to the data available on cyclothymic disorder and to
highlight areas in need of future research. A comprehensive review of the extant literature
was performed through PubMed and PsycInfo using the following search terms:
cyclothymia, cyclothymic disorder, subthreshold bipolar disorder, youth, pediatric and
pediatric bipolar disorder.
Epidemiology
Cyclothymic disorder, characterized by chronic mood instability – duration of at least 1 year
in children – is a debilitating, but rarely recognized disorder [6]. Although there is evidence
that cyclothymic disorder may be the most prevalent subtype of bipolar disorder in both
youth and adults [7–9], it is rarely diagnosed in children and is largely ignored in research
studies as most groups focus solely on the broad ‘bipolar not otherwise specified category’
(BP NOS) [10,11]. A recent meta-analysis of all the epidemiological studies of pediatric
psychiatric illness found that no component studies included cyclothymic disorder as a
distinct category. However, presentations of bipolar disorder that did not meet criteria for
bipolar I or II – but could be consistent with cyclothymic disorder – were the most prevalent
in young people [12]. These data are consistent with epidemiological studies in adults,
which also show that presentations of bipolar symptomatology that do not meet full criteria
for bipolar I or II are the most prevalent [13–15]. It can be inferred from these findings that
cyclothymic disorder is real and that it may persist into adulthood. However, the lack of
delineation of bipolar sutbtypes in pediatric epidemiological studies limits our knowledge of
cyclothymic disorder.
Assessment & diagnosis
The dearth of research on pediatric cyclothymic disorder compromises the field’s ability to
appropriately diagnose and treat youth with mood disorders. Because cyclothymic disorder
is not often included in research studies, it is likely that the diagnostic groups that are used
instead – primarily BP NOS – include youth with cyclothymic disorder. This
‘contamination’ of the diagnostic subgroup interferes with attempts to learn about the
etiology, course and optimal treatment for each of the bipolar subtypes.
The criteria for cyclothymic disorder are formally defined [1], whereas those for BP NOS
are intentionally vague, in order to capture presentations of bipolar disorder that fall outside
the DSM-defined subtypes. To meet criteria for the diagnosis of cyclothymic disorder, a
youth must have experienced 1 year for the duration of which they had hypomanic and
depressive symptoms without ever meeting the criteria for mania or major depression. By
contrast, a diagnosis of BP NOS is made when a person experiences symptoms of
hypomania and/or depression that do not meet criteria for mania or major depression.
Relying on the catchall diagnosis of BP NOS over a diagnosis of cyclothymic disorder is
understandable. The criteria for cyclothymic disorder raise challenges for clinicians.
Specifically, the chronic nature of cyclothymic disorder can be hard to differentiate from
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temperamental differences in young people. The diagnosis of any mood disorder requires a
discrete episode with cyclothymic disorder requiring a year-long episode, so details about
the timing of symptoms matter, but this does not mean that the clinician will have access to
reliable information. Retrospective reporting is notoriously fallible [16] and, when inquiring
about symptoms over the past year, it can be hard for the parent of a 7-year-old child to
delineate a year-long episode from ‘always’. Additionally, it can be hard to tell whether
symptoms of hypomania – irritability, elated mood and increased energy – are pathological,
or simply the signs of an active child. In such cases, another diagnosis – ADHD in the case
of predominantly elevated mood or depression in the case of low mood – may seem more
appropriate.
Further complicating diagnosis, diagnostic criteria for cyclothymic disorder overlap with
other disorders. In older adolescents and young adults, symptoms of cyclothymic disorder
may be confused with borderline personality disorder [17,18] or atypical depression [19,20].
These disorders all include significant mood instability and irritability and, in some cases,
may share an underlying cyclothymic temperament, making differential diagnosis
challenging. In youth, ADHD and depression, may both share characteristics with
cyclothymic disorder, including irritability, restlessness, moodiness and distractibility [1].
Both ADHD and depression are more common than cyclothymic disorder [21,22];
consequently, clinicians are more likely to have experience diagnosing and treating youth
with depression and/or ADHD.
Comorbid ADHD, which is common among children with bipolar disorder [23–27], further
clouds the diagnostic picture. In the typical clinic, with a focus on present symptomatology
and a desire to provide both children and parents with relief, a diagnosis of cyclothymic
disorder is not likely to be the most obvious choice, even if it is the most accurate.
Validation studies
Importantly, the diagnosis of cyclothymic disorder can be made reliably in youth. Two
validation studies on cyclothymic disorder in youth, using the criteria set out by Robins and
Guze [28], found that it can be reliably differentiated from other nonbipolar childhood
disorders, and that cyclothymic disorder falls on the bipolar spectrum based on multiple
criteria [29–31]. The first study, Improving the Assessment of Juvenile Bipolar Disorder,
included 827 youth, 52 of whom had a diagnosis of cyclothymic disorder (NIH
R01MH066647) [29]. The second study, using data collected under the auspices of a grant
from the Stanley Medical Research Institute (to RL Findling), provided a replication and
extension of the first, and included 894 youth, among whom 53 were cyclothymic disorder
cases [31]. Youth meeting DSM criteria for cyclothymic disorder were compared on a
variety of constructs with other youth with bipolar spectrum disorders (bipolar I and II, and
BP NOS), and to youth with nonbipolar spectrum disorders.
In both samples, youth with cyclothymic disorder experienced significantly higher levels of
irritability than nonbipolar youth – across both low and hypomanic mood states.
Importantly, youth with cyclothymic disorder also exhibited high levels of sleep disturbance
– significantly higher than nonbipolar cases. A decreased need for sleep is a hallmark
symptom of bipolar disorder and is often one of the best ways by which to differentiate
cyclothymic disorder, or other bipolar disorder subtypes, from nonbipolar childhood
disorders [32,33]. Youth with cyclothymic disorder also reported an early age of symptom
onset. Three-quarters had symptom onset before they were aged 10 years, and the average
age of onset for youth with cyclothymic disorder was 6 years. In the Improving the
Assessment of Juvenile Bipolar Disorder sample, youth with cyclothymic disorder had
symptom onset significantly earlier than youth with bipolar II or depression, suggesting that
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cyclothymic presentation might be a way of identifying those at risk of developing more
acute mood episodes prospectively.
Cyclothymic disorder was also associated with high comorbidity. Nearly all youth with
cyclothymic disorder, in both samples, had at least one comorbid axis I disorder, most
commonly ADHD. Related youth with cyclothymic disorder had high rates of psychiatric
illness among their family members: 100% of youth from the Stanley sample and 94% of
youth from the Improving the Assessment of Juvenile Bipolar Disorder sample had at least
one family member with a psychiatric illness, and most had a family member with bipolar
disorder. High comorbidity rates, along with the variability in heritable risk factors, could
provide some insight into the shared mechanisms across disorders, including bipolar
disorder, depression, ADHD, anxiety and borderline personality disorder. Across all the
constructs of interest – irritability, sleep disturbances, age of symptom onset, comorbid
diagnoses and family history – the two validation studies told a consistent story:
cyclothymic disorder occurs in young people, it can be reliably diagnosed and it shares more
in common with the other bipolar spectrum disorders than it does with the nonbipolar
spectrum disorders.
Genetics & temperament
Family studies and genome investigations offer another compelling piece of evidence that
cyclothymic disorder belongs on the bipolar spectrum [8,34–37]. The rates of familial
bipolar I are similar among people with cyclothymic disorder and those with bipolar I
[38,39]. Interestingly, this shared diathesis may manifest initially as cyclothymic
temperament [40,41]. Both people with bipolar disorder and their relatives tend to have
higher rates of cyclothymic temperament than healthy controls [42,43]. In children with
depression, cyclothymic temperament has been associated with a higher risk of bipolar
disorder and may be helpful in the prediction of future bipolarity among youth presenting
with depressed mood [44]. This could be particularly important because the treatment
guidelines for unipolar depression and bipolar depression are not the same [45,46]. Given
the aforementioned challenges of diagnosing cyclothymic disorder in youth, assessing for
both cyclothymic temperament and a family history of bipolar disorder can offer valuable
diagnostic information as part of a thorough evaluation.
Course
Cyclothymic disorder may begin earlier than other childhood disorders, perhaps owing to its
relation with temperament [44]. Early-onset bipolar disorder is thought to have a greater
genetic contribution than presentations of bipolar disorder that begin in late adolescence or
early adulthood [47]. In a study of young people whose parents had bipolar disorder, almost
a quarter of the offspring met criteria for cyclothymic disorder [36]. Additionally, in a study
of subsyndromal mania, youth who had at least one parent with a bipolar spectrum disorder
were more likely to exhibit bipolar symptoms, including irritability and mood lability, than
those youth whose parents did not have bipolar disorder [48]. Early-onset bipolar disorder is
associated with a more difficult course, including delayed diagnosis, treatment-resistant
symptoms, more frequent episodes and longer episodes [49,50], consistent with the
characteristics of cyclothymic disorder.
Although we know relatively little about the specific course of cyclothymic disorder in
youth because it has not been included in any longitudinal studies to date, adult studies
suggest that it is just as impairing as other subtypes of bipolar disorder [15]. Pediatric
studies indicate that symptom presentations consistent with cyclothymic disorder – chronic
moodiness as well as symptoms of both hypomania and depression – are associated with as
much impairment as bipolar I and II [10,51]. In our two validation studies, we found that
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youth with cyclothymic disorder had Children’s Global Assessment scores similar to those
with other bipolar spectrum disorders, but significantly worse than youth with nonbipolar
disorders [29–31]. Similarly, youth with bipolar spectrum disorders had a lower quality of
life than youth with serious medical illness, including heart disease, oxygen dependency,
arthritis, asthma, and obesity [52]. Although youth with cyclothymic disorder were not
directly compared with the other subtypes of bipolar disorder by Freeman et al., other
studies have found that the chronic nature of their symptoms results in fewer days of good
quality of life than others with bipolar I or II, for whom periods of euthymic mood are more
common [52].
Youth with cyclothymic disorder may experience factors contributing to poor quality of life
more often than other youth. In analyses concentrating on a case series at a community
mental health clinic, those with a diagnosis of cyclothymic disorder reported high rates of
abuse. According to parent reports, 26% of children had a history of neglect, 26% had a
history of sexual abuse and 20% had been physically abused. The rates of neglect and sexual
abuse were significantly higher than those reported by the parents of other treatment-seeking
youths with non-bipolar spectrum disorders [30]. Beyond this preliminary investigation, the
relationship between abuse and cyclothymic disorder in youth has not been specifically
explored. However, high rates are consistent with other research showing that abuse is more
prevalent among youth with bipolar spectrum disorders than youth with other psychiatric
disorders [53] and that abuse is associated with poor outcomes, including longer duration of
illness, both axis I and axis II comorbid diagnoses and a family history of mood disorders
[54–56].
Family history of psychiatric illness may contribute to high rates of abuse and neglect
among youth with cyclothymic disorder. As mentioned, family history of mental illness
appears ubiquitous with cyclothymic disorder [29,31]. This may also lead to less stable
home environments: 18% of youth with cyclothymic disorder in the Improving the
Assessment of Juvenile Bipolar Disorder sample had been placed out of home at least once.
Youth with cyclothymic disorder also experienced a significant disruption to their education:
78% had changed schools at least once, 36% had an individualized education plan, 45%
received special services at school and 72% were expelled from school at some point.
School problems are linked with a number of negative outcomes, including mental illness,
poor social support and incarceration [57]. Of the youth with cyclothymic disorder, 8%
already had a history of involvement with juvenile court, despite the average age of these
youths being 10 years.
Problems at school and involvement in the court system, in addition to other factors that
may be associated with having a child with mental illness, such as doctors’ appointments
and turmoil at home, take a toll on the family as well as the child [58]. In our sample, the
primary caregiver reported missing an average of 31 h of work in the preceding month due
to their child’s needs. Additionally, over a quarter of parents reported needing to seek
psychological treatment themselves, due to the stress of caring for their child [30]. Other
associated stressors, such as financial difficulties due to parents’ lost wages and the expense
of treating a chronic illness, are likely to further stress the family system and worsen the
course of the child’s illness.
Considering the accumulated risk factors, including school problems, parental mental
illness, and abuse that youth with cyclothymic disorder often experience, suggests a
deteriorating prognosis is suggested [59]. The outcome most feared by families and
clinicians is suicide. Bipolar disorder increases the risk for suicide, with a completion rate as
much as 20 times higher than among other suicide attempters [60,61]. In the Improving the
Assessment of Juvenile Bipolar Disorder sample, 45% of youth reported having suicidal
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thoughts, significantly higher than youth with nonbipolar disorders. Additionally, 18%
reported having engaged in nonsuicidal self injury, and 2% had made a potentially lethal
suicide attempt. These findings are concerning, but taking into account the young age of
these participants, and the fact that stressful life events of the type common among youth
with cyclothymic disorder [62] and prior suicidality are among the best predictors of future
suicide behavior [63–66], more attention to this group of youth is warranted. These results
align with the adult literature, consistently showing that subthreshold forms of bipolar
disorder are associated with significant suffering and should be a major public health
concern [15,67,68].
Sparse data leave ambiguity about the longterm prognosis for cyclothymic disorder. Studies
of young adults and adults, and child studies that lump BP NOS and cyclothymic disorder
together, suggest that approximately a third of cyclothymic disorder causes progress to
bipolar I or II [2,38,51,69]. Cyclothymic disorder has been conceptualized as a prodrome to
bipolar I or II [70]. In a longitudinal study of adolescents, approximately half of the
participants with cyclothymic disorder progressed to bipolar II disorder (had a major
depressive episode), whereas none of the participants who were diagnosed with
‘subthreshold bipolar’ disorder at enrollment continued to meet criteria for bipolar disorder
at follow-up [71]. This highlights the need to differentiate between cyclothymic disorder and
other subthreshold cases. Similarly, more than half (n = 7) of those with cyclothymic
disorder (n = 11) experienced an episode of mania or depression during the 3-year follow-up
[72]. Additionally, Kochman et al. found that 64% of youth with major depression combined
with cyclothymic temperament converted to bipolar disorder, versus only 15% of youth who
did not meet criteria for cyclothymic temperament [44]. Cyclothymic temperament was also
associated with an increased risk of suicidal ideation or attempt, with more than twice as
many youth with cyclothymic temperament than without reporting suicidal ideation or
attempts. Cyclothymic temperament, along with other factors that influence whether youth
with cyclothymic disorder develop bipolar I or II, has important clinical implications and
may help to inform treatment [35,73].
Intriguingly, there is also evidence for developmentally limited forms of bipolar disorder,
suggesting that some people meeting criteria for bipolar disorder in childhood will
experience permanent remission of their symptoms, beginning in young adulthood [74]. The
‘developmentally limited’ hypothesis may be one of the best arguments in favor of devoting
more resources toward investigating pediatric bipolar subtypes. Although data indicate that a
third of people with cyclothymic disorder develop bipolar I or II, the idea that subthreshold
forms of the disorder may remit has not been systematically explored. Identification of
factors moderating the progression of cyclothymic disorder would facilitate improved
treatments and preventive interventions. Unfortunately, without greater precision in the
diagnosis of bipolar spectrum disorders, the outcomes determined by the interaction of
different phenotypes and the environment are obscure (Figure 1).
Treatment
Little evidence guides effective intervention for cyclothymic disorder. Subthreshold
symptoms tend to persist longer than symptoms meeting full criteria [75,76] and, although
the discrete periods of hypomania and depression may be shorter than those associated with
bipolar I or II, the frequent fluctuation between mood states in cyclothymic disorder results
in fewer well (euthymic) days [77]. Youth with bipolar I or II tend to achieve remission
faster and enjoy extended periods relatively symptom free [51,78], whereas people with
cyclothymic disorder are generally symptomatic indefinitely [35]. Additionally, the more
chronic symptom presentation typical of cyclothymic disorder often indicates a
treatmentrefractory form of the disorder [51,78] associated with greater comorbidity [37,79].
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Research on psychosocial treatments for cyclothymic disorder is limited [80] and has not
been explored in a youth sample. Most studies of psychosocial treatments exclude
subthreshold cases. As a result, although there is growing evidence for the efficacy of
psychosocial treatment combined with pharmacotherapy for the treatment of bipolar
disorder, we do not know the extent to which psychotherapy would benefit youth with
cyclothymic disorder [81,82]. There are two published studies that evaluate the use of
cognitive behavioral therapy techniques to improve the symptoms of cyclothymic disorder
in adults [83,84]. Both produced results suggesting that the prognosis and quality of life for
people with cyclothymic disorder could be enhanced through augmented cognitive
behavioral therapy. Future research should build upon these results and progress toward
clear treatment guidelines for cyclothymic disorder, particularly in youth.
Psychopharmacological treatment
There are no randomized clinical trials focused on pharmacological treatment of
cyclothymic disorder, and extant treatment guidelines do not differentiate between
cyclothymic disorder and other bipolar disorders [85,86]. Studies that include youth with
symptom presentations similar to the diagnostic profile of cyclothymic disorder indicate that
the bipolar subtypes appear to respond to pharmaceutical treatment similarly [36,87].
Limited data from adult samples treating cyclothymic disorder with mood-stabilizing agents
suggest potential positive responses to agents such as lithium, valproate and other
anticonvulsants or antipsychotics [80,88]. Secondary analyses of the Improving the
Assessment of Juvenile Bipolar Disorder study data found that 63% of youth with
cyclothymic disorder were treated with a psychotropic medication, including stimulants,
antidepressants, mood stabilizers, antipsychotics (both typical and atypical), anticonvulsants
and lithium [30]. The lack of consistency regarding whether or not a child with cyclothymic
disorder is treated with medication and, if so, which medication is used, highlights the large
gap between the need for effective pharmaceutical interventions for cyclothymic disorder
and the current evidence. Although lacking rigorous scientific investigation, data suggest
that cyclothymic disorder responds to treatment as if it were on the bipolar spectrum, and
prudent approaches to treatment should use similar algorithms but perhaps start with lower
doses, titrating slowly.
Future directions
This review highlights that there are few data available specific to cyclothymic disorder in
youth. The literature has focused on bipolar I disorder and, when subtypes are included in
research projects, cyclothymic disorder is usually combined with cases that do not meet full
diagnostic criteria under a broad ‘bipolar disorder not otherwise specified’ category. Some
of these cases will continue to experience chronic mood dysregulation into adulthood.
Others will have a manic episode or major depressive episode and subsequently meet criteria
for bipolar I or II. However, some of these youth get better. Failing to carefully differentiate
the youth within this category greatly limits understanding of factors that influence
prognosis and intervention response.
The proposed addition of disruptive mood dysregulation disorder (DMDD) to the DSM-V
[101] could potentially lead to confusion with regard to cyclothymic disorder. DMDD and
its predecessors, severe mood dysregulation disorder and temper dysregulation disorder with
dysphoria, are based on limited data and have significant symptom overlap with other
childhood disorders [89]. Specifically, irritable mood with temper outbursts is the primary
criterion for DMDD and irritable mood can be the primary symptom of mania seen in
cyclothymic disorder. Furthermore, both diagnoses require a duration of 1 year. Alhough
DMDD has exclusion criteria that preclude the presence of other symptoms of mania, in the
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case of cyclothymic disorder full criteria for mania are never met, making a differential
diagnosis challenging [1,101]. Adult studies show that cyclothymic disorder is a prevalent
and impairing disorder. Further obscuring it in child research seems unwise. Research needs
to examine the boundaries between DMDD versus cyclothymic disorder and other childhood
disorders.
Conclusion & future perspective
As a whole, pediatric bipolar disorder is likely both under- and over-diagnosed [32], but
cyclothymic disorder is almost always undiagnosed in young people. Failing to consider a
diagnosis of cyclothymic disorder forces clinicians either to mislabel the disorder as not on
the bipolar spectrum (with the associated risks for treatment mismatch), to bundle it with BP
NOS or to ‘upgrade’ the diagnosis to bipolar I, contributing to concerns about overdiagnosis
and harmful treatment side effects. Early intervention is associated with a more positive
prognosis [73], but without accurate diagnosis there may be no benefits. Opportunities for
substantial amelioration of symptoms appear to be best with the subthreshold presentations
[90–92].
Cyclothymic disorder is well suited to a developmental psychopathology approach. The use
of longitudinal studies is necessary in order to better understand the risk factors, course,
treatment and outcomes of cyclothymic disorder in youth. This will also help to shed light
on the impairment associated with cyclothymic disorder and increase our awareness of the
burden of chronic mood dysregulation compared with acute mood symptomatology. There
are data suggesting that the chronicity of cyclothymic disorder results in greater impairment
than the relatively more severe symptoms found in bipolar I. Without prospective studies
that clearly delineate each of the bipolar subtypes, we will not know the answer to this
question, which is of high importance to public health.
Cyclothymic disorder is a prevalent and impairing disorder across the lifespan. Cyclothymic
disorder appears to belong on the bipolar spectrum, given the validation study data and
genetic data, but we know little about its course or its relation to temperament, depressive
disorders and other subthreshold bipolar disorders. The DSM and International
Classification of Diseases revisions provide an opportunity to consider how to best
conceptualize cyclothymic disorder: as a subtype of bipolar disorder, an affective
temperament, a diathesis, a prodrome or a personality style. The field would profit from
attention invested in cyclothymic disorder, a concept described for the past 130 years and
largely ignored for the past 20 years, at the expense of many young people and their future
quality of life.
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▪ Cyclothymic disorder occurs in youth and can be highly impairing.
▪ Cyclothymic disorder should be ruled out before a diagnosis of ‘bipolar not
otherwise specified’ is considered.
▪ The key to diagnosing cyclothymic disorder in youth is assessing for an
episode at least 1 year long, during which symptoms of both hypomania and
depression are present.
▪ An episode must be marked by a change in functioning and, for diagnosis of
cyclothymic disorder, associated with impairment.
▪ Treatment of cyclothymic disorder should follow the same guidelines that
exist for other bipolar spectrum disorders in youth.
▪ Psychosocial treatment for youth with cyclothymic disorder and their
families likely augments pharmacotherapy and contributes toward a better
prognosis.
Van Meter and Youngstrom Page 14














Common research practice of combining ‘bipolar not otherwise specified’ and cyclothymic
disorder, thereby obstructing the ability to identify factors affecting the course of illness and
subsequent outcomes.
BP NOS: Bipolar not otherwise specified.
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